Efficacy and safety of cabazitaxel therapy in elderly (≥75 years) patients with castration-resistant prostate cancer: A multiinstitutional study
- Resource Type
- Article
- Source
- In
Prostate International June 2021 9(2):96-100 - Subject
- Language
- ISSN
- 2287-8882